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This research project is intended to elucidate the structure and function of vanadium haloper-
oxidases as well as the causes and consequences of the chemical analogy between vanadate
and phosphate. In this context quantum chemical calculations mostly based on density func-
tional theory are performed on relevant model systems. Along this line an important question is
concerned with the role of the protein environment via supramolecular interactions. Although
particularly important for the cases considered here, such a supramolecular interplay between
metal centers and protein environment is a general feature for metalloenzymes.
1 Introduction
The interest in vanadium chemistry from a biological and pharmacological perspective has
exploded over the past 20 years. This is mainly based on the discoveries of the role of
vanadium as an insulin mimic, and the presence of vanadium in certain haloperoxidases
and nitrogenases1, 2. A key point for the understanding of how vanadium actually works
in biological systems is given by the chemical analogy between vanadates and phosphates.
One of the still open questions in this context is whether vanadate generally acts as a stable
transition state analog for phosphate blocking specific receptor sites or whether there are
cases for which the vanadate substitution actually leads to new active sites with a com-
pletely different reactivity with consequences for the pharmacological application and the
toxicity of vanadium.
2 Vanadium in Biological Systems
The biological function of vanadium is well established1, 2. Of particular importance is the
ability of vanadium to influence phosphate-metabolizing systems and the fact that vana-
dium is an inherent part of enzymatic active sites. For both types of vanadoenzymes known
today, the vanadium-containing haloperoxidases (see figure 1) and the vanadium nitroge-
nases from the nitrogen fixing bacteria Azotobacter, functional analogs are found in nature
which are either more widely spread or more efficient, e.g. the heme-containing haloper-
oxidases and the conventional nitrogenases with molybdenum cofactor, respectively. This
immediately leads to the question of how this enzyme systems did evolve and in particular
whether the vanadium-containing enzymes known today are retained functional analogs,
which simply could sustain evolutionary forces. New insight concerning these questions
may be gained on the basis of newly found similarities for vanadate and phosphate in bio-
logical systems3.
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Figure 1. Structure of the chloroperoxidase of the fungus Curvularia inaequalis determined by X-ray crystallog-
raphy.
The wide spread physiological effects of vanadium are mainly attributed to the
similarity between its anionic form, vanadate(V), and phosphate. But there are also
important differences between these two anions. At physiological pH values monovana-
date is found as doubly protonated [VO2(OH)2]− species, whereas phosphate occurs in
the monoprotonated form HPO2−4 . This is also important for possible mechanisms of
the transport systems for these two anions4–6. In addition vanadium is easily reduced
under physiological conditions to yield cationic species. The third difference is given
by the pronounced ability of vanadium to adopt higher coordination numbers. The
higher coordinative flexibility of vanadium can deliberately be used for the structural
characterization of phosphate metabolizing enzymes.
3 Phosphate-Vanadate-Analogy
Recently the crystal structures of several stable enzyme aggregates of phosphatases with
vanadate as transition state analog have been reported. An interesting example are the
protein tyrosine phosphatases7, 8, which are involved in signal transduction mechanisms
for controlling and regulating intracellular processes (e.g. the insulin receptor system) —
in this context it is worth noting that vanadate complexes show insulin-mimetic effects9.
In these aggregates the vanadium is trigonal bipyramidal and linked to the protein with a
single axial bound cysteine residue, whereas the oxygen atoms of the vanadate moiety are
involved in a hydrogen bonding network. A similar structure is found for the active site
of rat prostatic acid phosphatase with the complexed transition state analog vanadate10
(figure 2). In this case the vanadium is linked to the protein through an axial bound
histidine residue.
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Figure 2. Structure of the active site of the rat prostatic acid phosphatase with complexed vanadate. Hydrogen
bonds are shown as broken lines.
Striking similarities are observed for the only structurally characterized vanadoen-
zymes known today, the vanadium haloperoxidases - e.g. the chloroperoxidase of the
fungus Curvularia inaequalis (see figure 3)11–13. As in the case of the rat prostatic acid
phosphatase the vanadate is directly linked to the protein only through the axial bound
histidine residue and is embedded in the protein via an extensive hydrogen bonding
network.
Vanadium-containing haloperoxidases (V-HPO) are enzymes catalyzing the two elec-
tron oxidation of a halide (X−) to the corresponding hypohalous acid according to
Eq. (1)14.
H2O2 + X
− + H+ −→ H2O + HOX (1)
HOX may further react with a broad range of nucleophilic acceptors to form a diversity
of halogenated compounds. These haloperoxidases are named after the most electronega-
tive halide they are able to oxidize, and thus a vanadium chloroperoxidase (V-CPO) is able
to oxidize chloride, bromide and iodide.
Based on the recently published crystal structures of the native and apo forms as
well as the peroxide- and azide-bound derivatives of this chloroperoxidase11–13 several
interesting questions still remain and even new once have to be addressed: 1) What is the
electronic structure of the active site vanadate moiety, i.e. mono- or dioxovanadium(V)
species (VO3+ or VO+2 )? 2) How is the peroxo group or the chloride ion bound to the
active site? 3) What is the influence of the protein environment upon the structure of the
active site and the mechanism? 4) Does the apo-protein of this chloroperoxidase exhibit
105
Figure 3. Structure of the active site of vanadium haloperoxidase form the fungus Curvularia inaequalis. Hydro-
gen bonds are shown as broken lines.
phosphatase activity as expected based on its structural similarities to phosphatases?
Concerning the last question an interesting result has recently been published by
Wever et al., which were able to show that the apo-protein of the chloroperoxidase isolated
from the fungus Curvularia inaequalis indeed exhibits phosphatase activity15. Although
it is obvious from the kinetic data that the active site of this V-CPO is not optimized for
phosphatase activity, it is nevertheless clear that within the same supramolecular environ-
ment it is possible to catalyse two very different reactions such as those of haloperoxidases
and phosphatases. Consequently this structural motive should also be observed for the
active sites of other V-HPOs and phosphatases. Moreover, this structural similarity should
give rise to genetic relationships as well. According to the sequence alignment of relevant
enzymes nearly all amino acid residues coordinating vanadate in V-CPO isolated from
Curvularia inaequalis (Lys353, Arg360, Ser402, Gly403, His404, Arg490 and His496
see figure 3) are conserved in the V-HPOs sequenced thus far as well as within three
families of acid phosphatases (see figure 4)15. Within this active site architecture the
fully conserved histidine residues play an important role. His496 is the residue covalently
linking the vanadate to the protein, whereas His404 is essential for catalysis and is
proposed to function as an acid-base group. Together with the observed phosphatase
activity of the apo-protein of the V-CPO this indicates a very similar architecture of the
active sites of these V-HPOs and acid phosphatases.
The dendrogram depicted in figure 4 is based on the sequence alignment of 14 phos-
phatases and V-HPOs. These results indicate that these enzymes have divergently evolved
from a common ancestor. In combination with the observed stability of V-CPO from
106
Figure 4. Dendrogram based on the alignment of 14 acid phosphatases and vanadium haloperoxidases. The group
of membrane-bound phosphatases is marked with an M, and the group of soluble phosphatases is marked with
an S. Abbreviations: pgpB, phoshpatdiyl glycerophosphate phosphatase B; bcrC, gene product from Bacillus
licheniformis, no function has been assigned yet; G-6-Pase, glucose-6-phosphatase; phoC and phoN, class A
bacterial acid phosphatase; Apyrase, ATP-diphosphohydrolase; V-BPO, vanadium bromoperoxidase; V-CPO,
vanadium chloroperoxidase.
Curvularia inaequalis, which in particular resist a high concentration of their substrate
(H2O2) and their product (HOX) that would readily inactivate the heme-containing HPOs,
this contradicts the introductory hypothesis that V-HPOs are retained enzymatic systems
that simply could sustain evolutionary forces. This is further evidenced by the optimized
functionality of V-CPO from Curvularia inaequalis, that is given by its recently proposed
putative role as source for the starting material for the production of a chemical weapon,
the hydroxyl radical (see Eq. 2), which in turn can be used by the fungus to damage
the protective lignocellulose of plant tissues allowing the penetration of the plant cell for
nutrient acquisition16.
HOCl + (O2)
•− −→ (OH)• + Cl− + O2 (2)
It is remarkable, however, that for another class of acid phosphatases, that is ex-
emplified by the rat prostatic acid phosphatase (see figure 2), no sequence similarity is
found with the enzymes given in the dendrogram of figure 4. Nevertheless the observed
structural similarity of the active site, obvious from figures 2 and 3, indicates that a
convergent evolution seems to have occurred with respect to these enzyme systems.
Besides the interesting evolutionary aspects of these enzymes, there are also important
implications for both research in the acid phosphatase and in the V-HPO field. A first
remarkable example for this — in particular from an anthropocentric point of view — is
the structure of mammalian glucose-6-phosphatase (G-6-Pase). This enzyme catalyzes
the last step in both gluconeogenesis and glycogenolysis and as such it is the key enzyme
in glucose homeostasis. G-6-Pase deficiency is the cause of glycogen storage disease
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Figure 5. Membrane topology models for G-6-Pase. Left: Current six transmembrane-helix topology model.
Right: Newly proposed nine transmembrane-helix topology model. Putative G-6-Pase active site residues are
depicted as closed ovals.
type 1 (von Gierke disease) and is characterized by severe clinical manifestations such as
hypoglycemia, kidney enlargement or growth retardation, which usually cause an early
death of the patients.
The recently published model for the membrane topology of human G-6-Pase17 is not
consistent with the results outlined above and had to be modified accordingly as depicted
in figure 518. The active site residues of G-6-Pase identified by sequence alignment are
all situated on the same side of the membrane and are located within the helices II, III,
IV and V. In this new model the histidine residue His176 is the nucleophile forming the
phosphohistidine enzyme-substrate intermediate. The phosphate moiety is positioned by
interaction of the negatively charged oxygens with the positively charged amino acids
Lys76, Arg83 and Arg170. In analogy to the active site of V-CPO the residues Ser117 and
Gly118 may also donate hydrogen bonds and the histidine group His119 may provide the
proton needed to liberate the glucose moiety.
As shown by this first example, the common architecture of the active sites of
the vanadium-containing peroxidases and the aligned acid phosphatases has important
implications, that even reach into seemingly independent fields of research.
4 Mechanism of Vanadium Haloperoxidases
The current understanding of the catalytic activity of V-HPOs based on chemical,
biochemical and crystallographic data is summarized in figure 6. It raises new questions.
What controls the specific turnover activity, which can vary over 1000-fold depending on
the source of the enzyme? What defines the basis of the halide specificity in V-BPO and
V-CPO?
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Figure 6. Schematic representation of the current description of the catalytic activity of V-HPOs for the two
possible reactions (RH + H2O2 + HX→ RX + 2 H2O and 2 H2O2→ 2 H2O + O2.
To answer these questions a more detailed knowledge on the molecular mechanism
of the reactions at the active site is needed. In particular information on possible reaction
intermediates is not available at present. Therefore theoretical investigations on suitable
model systems including the supramolecular environment of the protein matrix are part of
the present project.
This leads to an additional point of interest related to the influence of the protein
environment on the particular reactivity of the active site. This is particularly important
since the apo-protein of the chloroperoxidase isolated from the fungus Curvularia
inaequalis exhibits phosphatase activity15. This clearly indicates that within the same
supramolecular environment it is possible to catalyse two very different reactions such as
those of haloperoxidases and phosphatases. A proposed mechanism for the phosphatase
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Figure 7. Schematic representation of the suggested mechanism for the catalytic activity of membrane bound
phosphatases (numbering scheme of the amino acids is related to the V-CPO structure (see figure 3).
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Figure 8. Structures of model systems for the supramolecular interaction of vanadate species with relevant protein
matrices.
activity of the V-HPO protein environment is depicted in figure 7.
5 Molecular Model Systems
For a detailed understanding of the reactivity of the biological systems described above
a comparison with chemical models is important. This is in particular the case when it
comes to the question of the influence of the protein environment on the reactivity. We
have synthesized a series of such model systems which exhibit hydrogen bonding at the
vanadate center related to the observed supramolecular environment of the native V-HPO
proteins (see figures 8)19, 20. The hydrogen bonding network for one of the model systems
as observed in the crystal structure is depicted in figure 9.
These model systems in addition also are used to calibrate the methodology of our
theoretical investigations. This is important, since the description of hydrogen bonds
within theoretical models is a difficult task.
Figure 9. Representation of the hydrogen bonding network for one of the model compounds depicted in figure
8 which exhibits features similar to the supramolecular environment of the active site structure of V-HPOs (see
figure 3).
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6 Computational Methods
The theoretical investigations related to this project are based on density functional (DFT)
calculations. The choice of both the appropriate density functional and the employed basis
sets is verified by calculations on model systems ranging from simple vanadate moieties
to molecular assemblies like the once depicted in figure 8. The mechanistic aspects for
the protein related systems are addressed by QM/MM methods in which the major part of
the protein environment is treated on a molecular mechanics (MM) basis and the key part
of the active site by quantum mechanics (QM). For medium sized systems representing
the active site structure including the important part of the supramolecular protein envi-
ronment also molecular dynamics simulations based on the Car-Parrinello method are part
of the project. All calculations have been performed at the computer center (ZAM) of the
Forschungszentrum Ju¨lich utilizing two massively-parallel computers (CRAY T3E-600
and CRAY T3E-1200) and a vector-parallel computer (CRAY T90). The computer system
used for a particular application depends on the efficiency of the implemented software
and the size of the molecular assembly to be calculated. For the QM/MM calculations and
the molecular dynamics simulations the CRAY massively-parallel computers turned out to
be essential tools with an average job size of 128 nodes with about 2 hours of CPU time.
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